Literature DB >> 20833079

Seizures and epilepsy in patients with a posterior circulation infarct.

Jacques L De Reuck1, Georges Van Maele.   

Abstract

Seizures occur mainly in patients with cortical infarcts in the anterior circulation. Those related to a posterior circulation infarct (POCI) are considered rare. This study investigated the characteristics of patients with seizures related to a POCI. A total of 180 consecutive patients admitted with a POCI had a 2- to 7-year follow-up; 24 of them (13.6%) developed seizures. Vascular risk factors, etiology and extension of the infarct, degree of neurologic impairment, and outcome were compared in the patients with and without seizures. Complex partial type seizure was the most common presentation. Stroke characteristics were largely the same in the patients with and without seizures. History of a previous stroke was noted in 62.5% of the seizure group and in 17.9% of the nonseizure group (P < .001). Clinical outcome was worse in the seizure group (P = .004). The relative incidence of seizures in patients with a POCI was not lower than that in the overall stroke population. The high incidence of recurrent stroke is the main risk factor for seizures in patients with a POCI. The seizures themselves are responsible for the increased dependence rate.
© 2012 National Stroke Association.

Entities:  

Mesh:

Year:  2010        PMID: 20833079     DOI: 10.1016/j.jstrokecerebrovasdis.2010.03.012

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

1.  Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis.

Authors:  Shubhang K Bhatt; Sara Dawit; Erin M Okazaki; Katherine H Noe
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-02-11

2.  Acute Basilar Artery Occlusion Presenting With Convulsive Movements: A Systematic Review.

Authors:  Dan Zhang; Yigang Chen; Yonggang Hao; Xingyue Hu; Xudong He
Journal:  Front Neurol       Date:  2022-01-07       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.